Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2013-06-05 · Food and Drug Administration, HHS · Notices

Notices. Correcting amendments

309 words·~1 min read·/register/2013/06/05/2013-13331·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 3510-33-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 522 [Docket No. FDA-2013-N-0002] New Animal Drugs; Dexmedetomidine; Lasalocid; Melengestrol; Monensin; and Tylosin; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Correcting amendments. SUMMARY: The Food and Drug Administration
(FDA)is correcting a document amending the animal drug regulations to reflect approval actions for new animal drug applications and abbreviated new animal drug applications during March 2013 that appeared in the **Federal Register** of April 30, 2013. FDA is correcting the approved strengths of dexmedetomidine hydrochloride injectable solution. This correction is being made to improve the accuracy of the animal drug regulations. DATES: This rule is effective June 5, 2013. FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9019, * ghaibel@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The Food and Drug Administration
(FDA)is correcting a document amending the animal drug regulations to reflect approval actions for new animal drug applications and abbreviated new animal drug applications during March 2013 that appeared in the **Federal Register** of April 30, 2013 (78 FR 25182). FDA is correcting the approved strengths of dexmedetomidine hydrochloride injectable solution. This correction is being made to improve the accuracy of the animal drug regulations. List of Subjects in 21 CFR Part 522 Animal drugs. Therefore, 21 CFR part 522 is corrected by making the following correcting amendment. PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 522 continues to read as follows: Authority: 21 U.S.C. 360b. 2. In § 522.558, revise paragraph
(a)to read as follows: § 522.558 Dexmedetomidine.
(a)*Specifications.* Each milliliter of solution contains 0.1 or 0.5 milligrams dexmedetomidine hydrochloride. Dated: May 31, 2013. Bernadette Dunham, Director, Center for Veterinary Medicine. [FR Doc. 2013-13331 Filed 6-4-13; 8:45 am]
Connectionstraces to 1
Traces to 1 document
1 reference not yet in our index
  • 21 CFR 522
Citation graph
cites case law
Notices
Correcting amendments
Cite21 CFR 522
Cites 2Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.